📊 Evidence-Based Reference

philips lumify diagnostic ultrasound system

Philips Healthcare

Summary: The Philips Lumify is a portable diagnostic ultrasound system designed for point-of-care imaging. It is primarily used for vascular and abdominal assessments. Key evidence highlights its feasibility for training and use in diverse clinical settings.

FDA Clearance Information

Pathway 510K
Decision Date October 30, 2015
Product Code IYN
Device Class Class 2
Evidence 419 studies

The Philips Lumify Diagnostic Ultrasound System was cleared by the FDA through the 510(k) pathway on October 30, 2015. It is manufactured by Philips Healthcare and classified as a Class 2 device under product code IYN.

What It Is

The Philips Lumify is a handheld ultrasound device that connects to a compatible smart device for real-time imaging. It is intended for diagnostic imaging in various clinical applications, including vascular and abdominal assessments.

Clinical Applications

Common clinical scenarios for the Philips Lumify include point-of-care assessments in emergency settings, vascular imaging, and monitoring of abdominal conditions. Its portability makes it suitable for use in both hospital and field environments.

Evidence Summary

The available literature includes 15 studies, comprising randomized controlled trials, systematic reviews, and performance assessments. The studies span from 2023 to 2025, focusing on the device's feasibility, imaging performance, and clinical applications.

Reported Outcomes

Published studies report that the Philips Lumify is effective in detecting abdominal hemorrhage and assessing vascular conditions. It demonstrates comparable imaging performance to traditional cart-based systems and is feasible for training non-specialist users.

Safety Profile

Reported complications include operator dependency, which may affect reliability in non-clinical settings. No significant adverse events were noted in the reviewed studies, indicating a favorable safety profile.

Evidence Limitations

Evidence gaps include a lack of large-scale studies directly comparing the Philips Lumify to other handheld devices. Further research is needed to explore long-term outcomes and its efficacy in diverse patient populations.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What are the clinical indications for Philips Lumify Diagnostic Ultrasound System?

The Philips Lumify is indicated for diagnostic imaging in vascular and abdominal assessments, particularly in point-of-care settings.

What outcomes have been reported in clinical studies?

Studies report effective detection of abdominal hemorrhage and vascular conditions, with imaging performance comparable to traditional systems.

What complications have been reported?

Safety data indicate operator dependency as a potential complication, but no significant adverse events have been reported.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.